Analysts project an 11.68% upside for the iShares U.S. Insurance ETF (IAK), with an implied target price of $147.87 based on the average analyst targets of its underlying holdings, compared to its recent trading price of $132.40. Kemper Corp (KMPR), MetLife Inc (MET), and Genworth Financial, Inc. (GNW), representing 5.12% of IAK, are highlighted as having significant upside potential of 30.31%, 22.30%, and 22.30% respectively, based on analyst target prices; however, the article suggests further investor research is needed to validate these targets.
The iShares U.S. Insurance ETF (Symbol: IAK) exhibits an implied analyst target price of $147.87 per unit, suggesting an 11.68% upside from its recent trading price of $132.40, based on a weighted average of analyst 12-month forward targets for its underlying holdings. Within this ETF, Kemper Corp (KMPR), MetLife Inc (MET), and Genworth Financial, Inc. (GNW) are highlighted for notable potential, collectively representing 5.12% of IAK's portfolio. Specifically, KMPR, recently trading at $63.08, has an average analyst target of $82.20, indicating a 30.31% upside. MetLife (MET), at $77.35, and Genworth Financial (GNW), at $6.95, both show a 22.30% upside to their respective average analyst targets of $94.60 and $8.50. While these figures and the associated moderately positive sentiment (overall sentiment score 0.4; KMPR 0.8, MET 0.7, GNW 0.7) point towards potential opportunities, the article underscores the need for further investor research to validate whether these analyst targets are justified or potentially overly optimistic, reflecting a cautious tone.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
